Mark Gladwin
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases (NCT02633397) | Mark Gladwin | 2017-04-11 |
| Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide (NO) Homeostasis (NCT01137656) | Mark Gladwin | 2010-04-01 |
Track Mark Gladwin automatically
Every clearance here is in the API, with alerts when new ones post.